Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study

This study evaluates patient satisfaction with receiving intravenous (IV) and/or subcutaneous (SC) immunotherapy and to assess patient preference for IV immunotherapy administration versus SC immunotherapy administration either at the hospital or at home.

NCT Number	NCT07339254
Lead Sponsor	University of Southern California Collaborators: National Cancer Institute (NCI), Bristol-Myers Squibb
Conditions	Lung Non-Small Cell Carcinoma
Enrollment	40 participants
Start Date	2026-03-12
Primary Completion	2027-03-12 (estimated)
Study Completion	2028-03-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-16